Journal rankings · indicator year 2019
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2019
Oncology journal rankings 2019
234 ranked journals · Subfield in Medicine
Oncology has 234 ranked journals in 2019. The median journal has an OJR of 0.79, below the world average of 1.00, down 0.03 on 2018; Q1 starts at OJR 1.31. The top three are CA A Cancer Journal for Clinicians, Nature Medicine, and The Lancet Oncology.
Ranks and citation indicators: 2019. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2016–2018, the window the 2019 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery936
- Pulmonary and Respiratory Medicine347
- Public Health, Environmental and Occupational Health299
- Cardiology and Cardiovascular Medicine290
- Oncology234
- Infectious Diseases217
- Epidemiology198
- Endocrinology, Diabetes and Metabolism168
- Neurology164
- Physiology160
- Radiology, Nuclear Medicine and Imaging153
- Psychiatry and Mental health142
Show all 42 subfields
- Orthopedics and Sports Medicine120
- Pediatrics, Perinatology and Child Health103
- Ophthalmology98
- Dermatology96
- Hematology80
- Obstetrics and Gynecology74
- Rheumatology67
- Nephrology58
- Complementary and alternative medicine54
- Pharmacology54
- Reproductive Medicine50
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology35
- Rehabilitation34
- Pathology and Forensic Medicine31
- Critical Care and Intensive Care Medicine24
- Genetics24
- Hepatology23
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology7
- Internal Medicine5
- Health Informatics4
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
234 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2018. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2016–2018, the window the 2019 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2016–2018 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2010 to 2019. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 105.99Q1 | 337.61 97.35 up from 2018 | 81 | 100% | $4,330 | ||
2Nature MedicineNature Portfolio · United States | 9.21Q1 | 26.46 5.24 up from 2018 | 828 | 50% | $12,690 | ||
3The Lancet OncologyElsevier BV · United Kingdom | 6.76Q1 | 17.39 1.32 down from 2018 | 1,131 | 31% | $7,280 | ||
4Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 6.39Q1 | 17.35 1.45 up from 2018 | 1,725 | 5% | — | ||
5Cancer CellCell Press · Netherlands | 6.38Q1 | 20.90 3.59 up from 2018 | 561 | 99% | $10,400 | ||
6Breast CareKarger Publishers · Switzerland | 5.19Q1 | 1.51 20.33 down from 2018 | 237 | 92% | — | ||
7JAMA OncologyAmerican Medical Association · United States | 4.15Q1 | 10.52 1.15 up from 2018 | 1,214 | 52% | — | ||
8Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 4.02Q1 | 11.15 2.17 up from 2018 | 439 | 51% | — | ||
9Annals of OncologyElsevier BV · Netherlands | 3.87Q1 | 11.79 2.31 up from 2018 | 1,371 | 100% | $5,080 | ||
10Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 3.33Q1 | 10.09 0.66 up from 2018 | 2,129 | 51% | — | ||
11Journal for ImmunoTherapy of CancerOABMJ · United Kingdom | 3.32Q1 | 11.85 2.86 up from 2018 | 347 | 100% | $2,490 | ||
12Journal of Hematology & OncologyOABioMed Central · United Kingdom | 3.25Q1 | 12.43 2.78 up from 2018 | 435 | 100% | $4,990 | ||
13European Journal of EpidemiologySpringer Science+Business Media · Italy | 3.18Q1 | 7.19 0.33 up from 2018 | 345 | 64% | $3,690 | ||
14Seminars in Cancer BiologyElsevier BV · United States | 3.13Q1 | 11.20 3.04 up from 2018 | 292 | 42% | $6,060 | ||
15Cancer DiscoveryAmerican Association for Cancer Research · United States | 3.04Q1 | 11.60 4.66 up from 2018 | 785 | 27% | — | ||
16JNCI Journal of the National Cancer InstituteOxford University Press · United States | 2.86Q1 | 8.67 0.26 up from 2018 | 582 | 94% | $5,436 | ||
17Cancer Immunology ResearchAmerican Association for Cancer Research · United States | 2.80Q1 | 9.02 0.10 down from 2018 | 380 | 20% | — | ||
18npj Precision OncologyOANature Portfolio · United Kingdom | 2.79Q1 | 8.76 1.59 up from 2018 | 68 | 100% | $4,090 | ||
19Nature Reviews Clinical OncologyNature Portfolio · United Kingdom | 2.67Q1 | 12.46 3.06 up from 2018 | 602 | 18% | — | ||
20Cancer Treatment ReviewsElsevier BV · United Kingdom | 2.64Q1 | 10.20 0.09 up from 2018 | 377 | 41% | $4,910 | ||
21Therapeutic Advances in Medical OncologyOASAGE Publishing · United Kingdom | 2.48Q1 | 8.23 2.02 up from 2018 | 161 | 100% | $2,800 | ||
22CancersOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.36Q1 | 7.37 0.33 down from 2018 | 832 | 100% | $3,499 | ||
23Oncology ReviewsOAPAGEPress (Italy) · Switzerland | 2.29Q1 | 7.23 1.07 up from 2018 | 44 | 100% | $2,353 | ||
24CancerWiley · United States | 2.29Q1 | 5.44 0.19 down from 2018 | 1,704 | 81% | $4,790 | ||
25British Journal of CancerSpringer Nature · United Kingdom | 2.08Q1 | 6.46 0.41 up from 2018 | 1,216 | 98% | $5,190 | ||
26Clinical Pharmacology & TherapeuticsWiley · United States | 2.02Q1 | 4.79 0.26 up from 2018 | 790 | 48% | $4,410 | ||
27Cancer Biology and MedicineOAChinese Anti-Cancer Association · China | 2.01Q1 | 6.28 0.84 up from 2018 | 132 | 100% | $1,500 | ||
28Clinical and Translational GastroenterologyOALippincott Williams & Wilkins · United States | 2.00Q1 | 4.55 0.72 down from 2018 | 209 | 100% | $2,800 | ||
29Frontiers in OncologyOAFrontiers Media · Switzerland | 1.99Q1 | 6.20 1.24 up from 2018 | 1,193 | 100% | $3,801 | ||
30npj Breast CancerOANature Portfolio · United States | 1.96Q1 | 6.26 1.06 down from 2018 | 115 | 100% | $3,790 | ||
31Breast Cancer ResearchOABioMed Central · United Kingdom | 1.95Q1 | 5.88 0.75 down from 2018 | 393 | 100% | $4,190 | ||
32Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 1.94Q1 | 4.60 0.55 down from 2018 | 640 | 100% | — | ||
33Current Oncology ReportsSpringer Science+Business Media · United States | 1.90Q1 | 5.03 0.22 up from 2018 | 254 | 18% | $5,090 | ||
34The OncologistOAAlphaMed Press · United Kingdom | 1.90Q1 | 4.68 0.56 down from 2018 | 780 | 100% | $3,852 | ||
35Current Treatment Options in OncologySpringer Science+Business Media · United States | 1.86Q1 | 4.89 0.14 up from 2018 | 211 | 14% | $4,890 | ||
36Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 1.83Q1 | 5.88 0.48 up from 2018 | 841 | 21% | — | ||
37Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 1.82Q1 | 5.38 1.18 up from 2018 | 341 | 30% | — | ||
38International Journal of CancerWiley · United States | 1.82Q1 | 5.58 0.39 up from 2018 | 1,753 | 87% | $5,030 | ||
39Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 1.74Q1 | 6.79 0.54 up from 2018 | 541 | 32% | $4,190 | ||
40OncoImmunologyOALandes Bioscience · United States | 1.73Q1 | 6.16 0.96 up from 2018 | 1,031 | 100% | $2,913 | ||
41Journal of Patient-Reported OutcomesOASpringer Nature · United Kingdom | 1.66Q1 | 3.35 1.29 up from 2018 | 79 | 100% | $1,990 | ||
42Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.64Q1 | 5.90 0.57 up from 2018 | 475 | 99% | $4,590 | ||
43ESMO OpenOAElsevier BV · Netherlands | 1.62Q1 | 4.97 0.60 up from 2018 | 289 | 100% | $3,910 | ||
44The Journal of Pathology Clinical ResearchOAWiley · United Kingdom | 1.60Q1 | 3.96 0.06 down from 2018 | 74 | 100% | $3,250 | ||
45Hematology/Oncology Clinics of North AmericaElsevier BV · United States | 1.59Q1 | 4.03 0.41 up from 2018 | 228 | 5% | $3,950 | ||
46Cancer Epidemiology Biomarkers & PreventionAmerican Association for Cancer Research · United States | 1.51Q1 | 4.38no change | 660 | 65% | — | ||
47Cancer ControlOASAGE Publishing · United States | 1.50Q1 | 4.13 1.61 up from 2018 | 136 | 100% | $2,650 | ||
48Annals of Gastroenterological SurgeryOAWiley · Japan | 1.46Q1 | 3.90 1.43 up from 2018 | 106 | 100% | $2,350 | ||
49Clinical Medicine Insights OncologyOASAGE Publishing · United Kingdom | 1.45Q1 | 2.33 2.34 down from 2018 | 53 | 100% | $2,650 | ||
50Cancer MedicineOAWiley · United Kingdom | 1.44Q1 | 4.21 0.32 up from 2018 | 1,249 | 100% | $4,700 |
Subfields of Medicine, with Oncology highlighted.
- Surgery936
- Pulmonary and Respiratory Medicine347
- Public Health, Environmental and Occupational Health299
- Cardiology and Cardiovascular Medicine290
- Oncology234
- Infectious Diseases217
- Epidemiology198
- Endocrinology, Diabetes and Metabolism168
- Neurology164
- Physiology160
- Radiology, Nuclear Medicine and Imaging153
- Psychiatry and Mental health142
- Orthopedics and Sports Medicine120
- Pediatrics, Perinatology and Child Health103
- Ophthalmology98
- Dermatology96
- Hematology80
- Obstetrics and Gynecology74
- Rheumatology67
- Nephrology58
- Complementary and alternative medicine54
- Pharmacology54
- Reproductive Medicine50
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology35
- Rehabilitation34
- Pathology and Forensic Medicine31
- Critical Care and Intensive Care Medicine24
- Genetics24
- Hepatology23
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology7
- Internal Medicine5
- Health Informatics4
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
Journals
Citations made in 2019. Corpus-wide, 83.4% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
73 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2016–2018, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2019. Publication window: 2016–2018. How these summaries are calculated
- Ranked journals
- 234
- Window papers (baseline)
- 115,044 +11.8% from indicator year 2016
- Median OJR
- 0.79 -4.8% from indicator year 2016
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2016–2018 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.